Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-04-14 Sale | 2023-04-18 8:57 pm | Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner | 2,190,549 | $24.32 | $53,274,152 | 15,994,428 (Direct) | View |
2023-02-10 Sale | 2023-02-14 7:19 pm | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 75,985 | $10.09 | $766,549 | 3,083,191 (Indirect Direct) | View |
2023-02-10 Sale | 2023-02-14 7:16 pm | Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer | 4,500 | $10 | $45,005 | 0 (Direct) | View |
2023-02-10 Sale | 2023-02-14 7:13 pm | Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO | 75,835 | $10.09 | $765,003 | 3,479,325 (Direct) | View |
2023-01-18 Sale | 2023-01-20 8:00 pm | Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO | 24,165 | $10.27 | $248,063 | 3,087,605 (Direct) | View |
2023-01-18 Sale | 2023-01-20 8:00 pm | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 24,015 | $10.27 | $246,584 | 2,891,088 (Indirect Direct) | View |
2023-01-18 Sale | 2023-01-20 4:10 pm | Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner | 3,000,000 | $9.4 | $28,200,000 | 11,879,023 (Direct) | View |
2022-12-29 Sale | 2022-12-30 4:01 pm | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 187,000 | $10.26 | $1,918,601 | 2,915,103 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-04-27 Equity Swap | 2023-04-28 4:18 pm | N/A N/A | Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner | 15,567,497 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:09 pm | N/A N/A | Provention Bio Inc. | PRVB | Wysenski Nancy Director | 207,181 | $0 | 0 (Direct) | View |
2023-04-27 Equity Swap | 2023-04-27 6:07 pm | N/A N/A | Provention Bio Inc. | PRVB | Pisano Wayne Director | 7,500 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:07 pm | N/A N/A | Provention Bio Inc. | PRVB | Pisano Wayne Director | 231,181 | $0 | 0 (Direct) | View |
2023-04-27 Equity Swap | 2023-04-27 6:06 pm | N/A N/A | Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO | 2,570,050 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:06 pm | N/A N/A | Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO | 2,178,970 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:04 pm | N/A N/A | Provention Bio Inc. | PRVB | Jenkins John Kenneth Director | 184,981 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:03 pm | N/A N/A | Provention Bio Inc. | PRVB | Jain Rita Director | 66,000 | $0 | 0 (Direct) | View |
2023-04-27 Equity Swap | 2023-04-27 6:02 pm | N/A N/A | Provention Bio Inc. | PRVB | CATLIN AVERY W Director | 10,000 | $0 | 0 (Indirect) | View |
2023-04-27 Disposition | 2023-04-27 6:02 pm | N/A N/A | Provention Bio Inc. | PRVB | CATLIN AVERY W Director | 231,181 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:01 pm | N/A N/A | Provention Bio Inc. | PRVB | Yi Miyoko Christina Chief Operations Officer | 537,000 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:01 pm | N/A N/A | Provention Bio Inc. | PRVB | Vogel Justin Chief Accounting Officer | 413,185 | $0 | 0 (Direct) | View |
2023-04-27 Equity Swap | 2023-04-27 6:01 pm | N/A N/A | Provention Bio Inc. | PRVB | Ramos Eleanor Chief Medical Officer | 70,000 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:01 pm | N/A N/A | Provention Bio Inc. | PRVB | Ramos Eleanor Chief Medical Officer | 1,492,712 | $0 | 0 (Direct) | View |
2023-04-27 Equity Swap | 2023-04-27 6:01 pm | N/A N/A | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 2,573,000 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:01 pm | N/A N/A | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 1,274,353 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:00 pm | N/A N/A | Provention Bio Inc. | PRVB | Osorio Benedict Chief Quality Officer | 437,000 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:00 pm | N/A N/A | Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer | 1,022,250 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:00 pm | N/A N/A | Provention Bio Inc. | PRVB | King-Jones Heidy Chief Legal Officer | 784,500 | $0 | 0 (Direct) | View |
2023-04-27 Disposition | 2023-04-27 6:00 pm | N/A N/A | Provention Bio Inc. | PRVB | Chauche Thierry Chief Financial Officer | 625,000 | $0 | 0 (Direct) | View |
2023-04-20 Gift | 2023-04-24 4:18 pm | N/A N/A | Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner | 426,931 | $0 | 15,567,497 (Direct) | View |
2023-04-14 Exercise | 2023-04-18 8:57 pm | N/A N/A | Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner | 8,879,023 | $6 | 15,994,428 (Direct) | View |
2023-04-14 Exercise | 2023-04-18 8:57 pm | 2022-07-13 2027-07-13 | Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner | 8,879,023 | $0 | 15,994,428 (Direct) | View |
2023-04-13 Gift | 2023-04-14 6:10 pm | N/A N/A | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 1,500,000 | $0 | 146,000 (Direct) | View |
2023-04-13 Gift | 2023-04-14 5:24 pm | N/A N/A | Provention Bio Inc. | PRVB | CATLIN AVERY W Director | 10,000 | $0 | 20,000 (Direct) | View |
2023-03-31 Other | 2023-04-04 8:10 pm | N/A N/A | Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner | 3,000,000 | $0 | 3,426,931 (Direct) | View |
2023-04-04 Gift | 2023-04-04 8:10 pm | N/A N/A | Provention Bio Inc. | PRVB | Sessa Capital (Master) L.P. Sessa Capital GP LLC Sessa Capital IM L.P. Sessa Capital IM GP LLC Petry John 10% Owner | 218,651 | $0 | 3,426,931 (Direct) | View |
2023-02-10 Exercise | 2023-02-14 7:19 pm | N/A N/A | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 75,985 | $2.5 | 3,083,191 (Direct) | View |
2023-02-10 Exercise | 2023-02-14 7:19 pm | N/A 2027-04-25 | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 75,985 | $0 | 3,083,191 (Direct) | View |
2023-02-10 Exercise | 2023-02-14 7:13 pm | N/A N/A | Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO | 75,835 | $2.5 | 3,479,325 (Direct) | View |
2023-02-10 Exercise | 2023-02-14 7:13 pm | N/A 2027-04-25 | Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO | 75,835 | $0 | 3,479,325 (Direct) | View |
2023-01-18 Exercise | 2023-01-20 8:00 pm | N/A N/A | Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO | 24,165 | $2.5 | 3,087,605 (Direct) | View |
2023-01-18 Exercise | 2023-01-20 8:00 pm | N/A 2027-04-25 | Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO | 24,165 | $0 | 3,087,605 (Direct) | View |
2023-01-18 Exercise | 2023-01-20 8:00 pm | N/A N/A | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 24,015 | $2.5 | 2,891,088 (Direct) | View |
2023-01-18 Exercise | 2023-01-20 8:00 pm | N/A 2027-04-25 | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 24,015 | $0 | 2,891,088 (Direct) | View |
2023-01-17 Option Award | 2023-01-18 4:01 pm | N/A 2033-01-17 | Provention Bio Inc. | PRVB | Palmer Ashleigh Director and CEO | 700,000 | $0 | 700,000 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 9:17 pm | N/A 2033-01-10 | Provention Bio Inc. | PRVB | Vogel Justin Chief Accounting Officer | 84,000 | $0 | 84,000 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 9:16 pm | N/A 2033-01-10 | Provention Bio Inc. | PRVB | Ramos Eleanor Chief Medical Officer | 210,000 | $0 | 210,000 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 9:15 pm | 2023-01-10 2031-12-16 | Provention Bio Inc. | PRVB | Yi Miyoko Christina Chief Operations Officer | 208,000 | $0 | 409,000 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 9:14 pm | N/A 2033-01-10 | Provention Bio Inc. | PRVB | Osorio Benedict Chief Quality Officer | 187,000 | $0 | 187,000 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 9:13 pm | 2023-01-10 2032-09-15 | Provention Bio Inc. | PRVB | O'Brien Sarah Chief People Officer | 108,000 | $0 | 208,000 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 9:12 pm | N/A 2033-01-10 | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 210,000 | $0 | 210,000 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 9:11 pm | N/A 2033-01-10 | Provention Bio Inc. | PRVB | King-Jones Heidy Chief Legal Officer | 200,000 | $0 | 200,000 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 9:10 pm | N/A 2033-01-10 | Provention Bio Inc. | PRVB | Hoitt Jason Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 9:10 pm | N/A 2033-01-10 | Provention Bio Inc. | PRVB | Chauche Thierry Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 4:31 pm | N/A 2033-01-03 | Provention Bio Inc. | PRVB | Jain Rita Director | 66,000 | $0 | 66,000 (Direct) | View |
Ownership | 2023-01-05 4:26 pm | N/A 2028-07-19 | Provention Bio Inc. | PRVB | Vogel Justin Chief Accounting Officer | 0 | $0 | 329,185 (Direct) | View |
2022-12-29 Exercise | 2022-12-30 4:01 pm | N/A N/A | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 187,000 | $2.5 | 2,915,103 (Direct) | View |
2022-12-29 Exercise | 2022-12-30 4:01 pm | N/A 2027-04-25 | Provention Bio Inc. | PRVB | Leon Francisco Chief Scientific Officer | 187,000 | $0 | 2,915,103 (Direct) | View |